Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06593119 · ClinicalTrials.gov registry record · NA

Tailoring TM-HTN Intervention for Black Patients

A NA study, sponsored by Wake Forest University Health Sciences.

Not yet
Registry status
NA
Development phase
60
Enrollment target

NCT06593119 is a NA study that has not yet begun recruiting, run by Wake Forest University Health Sciences. The registered enrollment target is 60 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06593119, a NA study, has not yet begun recruiting, sponsored by Wake Forest University Health Sciences.

NOT YET RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

Current clinic-based hypertension (HTN) management models have several limitations, resulting in episodic care that does not adequately support patients' self-care skills, and fails to achieve blood pressure (BP) control.

Interventions

  • BEHAVIORAL Usual Care
  • BEHAVIORAL Telemedicine management of Hypertension

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2026-08
Est. Completion 2028-08
Phase NA

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT06593119

The ClinicalTrials.gov registry entry for NCT06593119 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.

NCT06593119 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06593119 about?

NCT06593119 is a clinical study titled "Tailoring TM-HTN Intervention for Black Patients". Current clinic-based hypertension (HTN) management models have several limitations, resulting in episodic care that does not adequately support patients' self-care skills, and fails to achieve blood pressure (BP) control.

What is the current status of trial NCT06593119?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-08. Estimated completion is 2028-08.

What interventions are being tested in trial NCT06593119?

The interventions under investigation include: Usual Care (BEHAVIORAL), Telemedicine management of Hypertension (BEHAVIORAL).

Who is sponsoring clinical trial NCT06593119?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.